EXACT SCIENCES CORP (CIK: 0001124140) EDGAR, Information, Filings... CompaniesBIO.Com

EXACT SCIENCES CORP

Mailing address
5505 ENDEAVOR LANE, MADISON, Delaware, 53719
Phone
608-284-5700
State location
Wisconsin
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES
Filings
N/A

EXACT SCIENCES CORP (CIK: 0001124140) is an American company incorporated in the state of Wisconsin. Head office is located at 5505 ENDEAVOR LANE, MADISON, Wisconsin, 53719. Work in the industry 8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES. EXACT SCIENCES CORP is a public company and trade via Over-The-Counter (OTC).

Old names:

EXACT CORP from 2000-07-Dec to 2001-08-Jan

Owner	Filings	Transaction Date	Type of Owner
Herriott James	0001957680	Dec-30-2022	officer: General Counsel
Baranick Brian	0001941313	Aug-04-2022	officer: Gen. Mgr., Precision Oncology
Cunningham Everett	0001564777	Nov-01-2021	officer: Chief Commercial Officer
Clancy Paul J	0001409601	Mar-18-2021	director
Condella Sarah	0001839989	Dec-30-2020	officer: SVP, Human Resources
Petrovic Shacey	0001631895	Jul-22-2020	director
Lewis-Hall Freda C	0001437909	Apr-22-2020	director
Paulsen Gisela	0001807104	Apr-20-2020	officer: Gen Mgr, Precision Oncology
ORVILLE JACOB A	0001263312	Nov-11-2019	officer: General Manager, New Ventures
Cole G Bradley	0001337798	Nov-11-2019	officer: General Manager - Diagnostics
Hoof Torsten	0001774167	Nov-11-2019	officer: General Manager, International
Slavitt Andrew M	0001411209	Jul-25-2019	director
Jacquet Pierre	0001783451	Jul-25-2019	director
Hooker Ana	0001774825	Apr-24-2019	officer: SVP, Operations
Sebelius Kathleen	0001654316	Mar-03-2019	director
Johnson Scott C.	0001764247	Jan-01-2019	officer: SVP - Research and Development
Stenhouse Mark	0001734751	Apr-02-2018	officer: President, Cologuard
Casdin Eli	0001534264	Oct-26-2017	director
Elliott Jeffrey Thomas	0001689757	Nov-08-2016	officer: Chief Financial Officer
Fallon John A.	0001560152	Jan-25-2016	director
BAKEWELL JOHN K	0001183553	Jan-01-2016	officer: Chief Financial Officer
WYZGA MICHAEL S	0001201256	Feb-09-2015	director
COWARD D SCOTT	0001247296	Jan-01-2015	officer: SVP and General Counsel
Doyle James Edward	0001614265	Jul-24-2014	director
Megan William J.	0001586947	Aug-26-2013	officer: SVP, Finance & PFO
Carey Thomas D.	0001574633	Apr-29-2013	director
Stoltenberg Laura S	0001544154	Mar-19-2012	officer: Chief Commercial Officer
Krayacich John M	0001515647	Mar-15-2011	officer: SVP, Sales and Marketing
THOMPSON DAVID	0001163761	Jul-16-2010	director
LEVANGIE DANIEL J	0001187406	Jul-16-2010	director
Sterling Lionel	0001302394	Jul-16-2010	director
Berger Barry M	0001475128	Oct-14-2009	officer: Chief Medical Officer
LIDGARD GRAHAM PETER	0001216274	Aug-03-2009	officer: SVP, Chief Scientific Officer
Connelly James P	0001334495	Apr-24-2009	director
Napier Katherine S	0001367313	Apr-24-2009	director
ARORA MANEESH	0001263311	Mar-18-2009	officer: Vice President
Conroy Kevin T	0001306119	Mar-18-2009	director, officer: Vice President
Singer Michael E	0001450842	Nov-23-2008	director
Nikka David	0001407602	Jul-18-2007	officer: Chief Operating Officer
WILCOX HARRY W	0001079136	Feb-16-2006	officer: Senior Vice President and CFO
MCGILLICUDY CORNELIUS III	0001136998	Jul-22-2005	director
ZENNER PATRICK J	0001139036	Jul-22-2005	director
LAPIDUS STANLEY N	0001166721	Jul-22-2005	director
CRAWFORD SALLY	0001199735	Jul-22-2005	director
WILLSEY LANCE	0001202106	Jul-22-2005	director
HARDISON DON M	0001209588	Feb-17-2005	director, officer: President and C.E.O
SHUBER ANTHONY P	0001209587	Dec-23-2004	officer: Chief Tech Officer & Sen. V.P.
LUBER JEFFREY R	0001268566	Dec-23-2004	officer: General Counsel
Carelli Charles R Jr	0001308266	Nov-09-2004	officer: Prin. Acct. Off. & Corp. Ctlr.
KANIA EDWIN M JR	0001255927	Jul-23-2004	director
READ STEPHEN A	0001286516	Apr-07-2004	officer: Interim CFO,VP,Corp Controller
MCCARTHY JOHN A JR	0001209585	Feb-11-2004	officer: Chief Financial Officer
BARKER RICHARD W	0001255954	Jul-18-2003	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by EXACT SCIENCES CORP

Filings	Format	Description	Filed/Effective	File/Film Number
SCHEDULE 13G/A	Document	Acc-no: 0000315066-25-002960 (34 Act) Size: KB	Dec-05-2025	005-62447 251552358
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001193125-25-300474 (34 Act) Size: KB	Nov-26-2025	001-35092 251529955
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001193125-25-291700 (34 Act) Size: KB	Nov-24-2025	001-35092 251509300
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-291651 ( Act) Size: 0 KB	Nov-21-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-291649 ( Act) Size: 0 KB	Nov-21-2025
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001193125-25-290038 (34 Act) Size: KB	Nov-20-2025	001-35092 251503987
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001193125-25-289962 (34 Act) Size: KB	Nov-20-2025	001-35092 251503744
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001193125-25-289955 (34 Act) Size: KB	Nov-20-2025	001-35092 251503735
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001193125-25-289953 (34 Act) Size: KB	Nov-20-2025	001-35092 251503728
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001193125-25-289949 (34 Act) Size: KB	Nov-20-2025	001-35092 251503724
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001193125-25-288902 (34 Act) Size: KB	Nov-20-2025	001-35092 251501039
8-K	Document	Current report filing Acc-no: 0001193125-25-288896 (34 Act) Size: KB	Nov-20-2025	001-35092 251501034
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-25-007136 (33 Act) Size: 0 KB	Nov-19-2025	001-35092 251498873
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-25-007133 (33 Act) Size: 0 KB	Nov-19-2025	001-35092 251497676
SCHEDULE 13G/A	Document	Acc-no: 0001422849-25-000083 (34 Act) Size: KB	Nov-13-2025	005-62447 251480413
SCHEDULE 13G/A	Document	Acc-no: 0000902219-25-000401 (34 Act) Size: KB	Nov-12-2025	005-62447 251469815
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-270168 ( Act) Size: 0 KB	Nov-06-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-270166 ( Act) Size: 0 KB	Nov-06-2025
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-25-006707 (33 Act) Size: 0 KB	Nov-04-2025	001-35092 251446981
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-25-006705 (33 Act) Size: 0 KB	Nov-04-2025	001-35092 251446972

Recent 20 filings. View all EXACT SCIENCES CORP filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

EXACT SCIENCES CORP overview
EXACT SCIENCES CORP job
EXACT SCIENCES CORP stock
EXACT SCIENCES CORP ownership
EXACT SCIENCES CORP CEO
EXACT SCIENCES CORP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.